-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We
-
, synaptic neoteny, and neurodevelopmental disorders. The labs are located at NERF and VIB-KU Leuven Center for Brain & Disease Research is part of the VIB Life Sciences Institute and is embedded within KU
-
candidates to join us starting autumn 2026! Our different research groups explore how the brain and nervous system develops, ages and functions in health and disease, in particular neurodegenerative and
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
block within this process. You will be embedded both within an experimental and computational team, providing a unique atmosphere where there is expertise to develop the deep-learning models while having
-
change in identity in all other cells, often resulting in molecular states that are eerily similar to those observed in diseases. How these intercellular cascades are exactly wired is poorly understood
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the functional specialization of liver macrophages. This project is supported by an ERC
-
). The position is available upon agreement. For further information visit https://brunnerlab.sites.vib.b... and contact Prof. Janine Brunner (janine.brunner@vub.be).
-
movement disorders and longitudinal cohort management. Together we offer a highly collaborative, translational environment embedded in VIB and the University of Antwerp. Position Drive a clinical
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the molecular mechanisms driving liver regeneration. This project is supported by